Income Statement Max Healthcare Institute Limited
Equities
MAXHEALTH
INE027H01010
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,053.65 INR | -0.87% |
|
+1.32% | +0.84% |
| 02-09 | JM Financial Downgrades Max Healthcare Institute to Reduce from Add; Price Target is INR988 | MT |
| 02-06 | Max Healthcare Institute Limited, Q3 2026 Earnings Call, Feb 06, 2026 |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 25.05B | 39.31B | 45.63B | 54.06B | 70.28B | |||||
Other Revenues, Total | 33M | - | - | - | - | |||||
Total Revenues | 25.08B | 39.31B | 45.63B | 54.06B | 70.28B | |||||
Cost of Goods Sold, Total | 12.32B | 17.48B | 18.01B | 20.53B | 26.51B | |||||
Gross Profit | 12.76B | 21.83B | 27.61B | 33.53B | 43.77B | |||||
Selling General & Admin Expenses, Total | 5.66B | 8.73B | 10.69B | 11.17B | 14.75B | |||||
Provision for Bad Debts | 323M | - | - | - | - | |||||
Depreciation & Amortization - (IS) | 1.74B | 2.21B | 2.32B | 2.45B | 3.59B | |||||
Other Operating Expenses | 2.6B | 3.36B | 4.36B | 7.16B | 10.16B | |||||
Other Operating Expenses, Total | 10.32B | 14.31B | 17.37B | 20.78B | 28.5B | |||||
Operating Income | 2.43B | 7.53B | 10.24B | 12.75B | 15.28B | |||||
Interest Expense, Total | -1.71B | -900M | -713M | -446M | -1.49B | |||||
Interest And Investment Income | 767M | 751M | 1.12B | 1.56B | 1.17B | |||||
Net Interest Expenses | -943M | -149M | 411M | 1.12B | -315M | |||||
Income (Loss) On Equity Invest. | -230M | - | - | - | - | |||||
Currency Exchange Gains (Loss) | 179M | -3.4M | -2.4M | 3M | -7M | |||||
Other Non Operating Income (Expenses) | 67.4M | 258M | 86.7M | 41.6M | 204M | |||||
EBT, Excl. Unusual Items | 1.5B | 7.63B | 10.74B | 13.91B | 15.16B | |||||
Restructuring Charges | - | -90.3M | - | - | - | |||||
Merger & Related Restructuring Charges | -378M | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | -2.4M | -30.6M | 13.3M | 4.5M | 1.1M | |||||
Asset Writedown | -81.4M | -600K | - | - | - | |||||
Other Unusual Items | -1.96B | -124M | -111M | -265M | -1.1B | |||||
EBT, Incl. Unusual Items | -917M | 7.39B | 10.64B | 13.65B | 14.06B | |||||
Income Tax Expense | 458M | 1.34B | -398M | 3.08B | 3.3B | |||||
Earnings From Continuing Operations | -1.38B | 6.05B | 11.04B | 10.58B | 10.76B | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | -1.38B | 6.05B | 11.04B | 10.58B | 10.76B | |||||
Minority Interest | - | - | - | - | - | |||||
Net Income - (IS) | -1.38B | 6.05B | 11.04B | 10.58B | 10.76B | |||||
Preferred Dividend and Other Adjustments | - | - | - | - | - | |||||
Net Income to Common Incl Extra Items | -1.38B | 6.05B | 11.04B | 10.58B | 10.76B | |||||
Net Income to Common Excl. Extra Items | -1.38B | 6.05B | 11.04B | 10.58B | 10.76B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -1.59 | 6.25 | 11.38 | 10.89 | 11.07 | |||||
Basic EPS - Continuing Operations | -1.59 | 6.25 | 11.38 | 10.89 | 11.07 | |||||
Basic Weighted Average Shares Outstanding | 863M | 967M | 970M | 972M | 972M | |||||
Net EPS - Diluted | -1.59 | 6.24 | 11.36 | 10.84 | 11.01 | |||||
Diluted EPS - Continuing Operations | -1.59 | 6.24 | 11.36 | 10.84 | 11.01 | |||||
Diluted Weighted Average Shares Outstanding | 863M | 969M | 972M | 975M | 977M | |||||
Normalized Basic EPS | 1.09 | 4.93 | 6.92 | 8.95 | 9.75 | |||||
Normalized Diluted EPS | 1.09 | 4.92 | 6.9 | 8.92 | 9.69 | |||||
Dividend Per Share | - | - | 1 | 1.5 | 1.5 | |||||
Payout Ratio | - | - | - | 9.17 | 13.53 | |||||
Supplemental Items | ||||||||||
EBITDA | 3.9B | 9.41B | 12.23B | 14.82B | 18.31B | |||||
EBITA | 2.8B | 7.97B | 10.69B | 13.18B | 15.7B | |||||
EBIT | 2.43B | 7.53B | 10.24B | 12.75B | 15.28B | |||||
EBITDAR | 4.06B | 9.6B | 12.48B | - | - | |||||
Total Revenues (As Reported) | 26.19B | 40.59B | 47.02B | 55.84B | 71.84B | |||||
Effective Tax Rate - (Ratio) | -50 | 18.11 | -3.74 | 22.54 | 23.5 | |||||
Current Domestic Taxes | - | 1.16B | 2.05B | 2.71B | - | |||||
Total Current Taxes | 16.2M | 1.16B | 2.05B | 2.71B | 3.36B | |||||
Deferred Domestic Taxes | - | 180M | -2.45B | 364M | - | |||||
Total Deferred Taxes | 434M | 180M | -2.45B | 364M | -56.2M | |||||
Normalized Net Income | 940M | 4.77B | 6.71B | 8.7B | 9.47B | |||||
Interest Capitalized | - | - | - | - | - | |||||
Interest on Long-Term Debt | 170M | 192M | 168M | 152M | 445M | |||||
Non-Cash Pension Expense | 36.6M | 37.7M | 41.3M | 48.5M | 57.8M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 168M | 446M | 576M | - | - | |||||
Selling and Marketing Expenses | 168M | 446M | 576M | - | - | |||||
General and Administrative Expenses | 5.33B | 8.09B | 9.86B | 11.17B | 14.75B | |||||
Research And Development Expense From Footnotes | 57.3M | 3.28M | 3.6M | 5.11M | 7.56M | |||||
Net Rental Expense, Total | 160M | 188M | 250M | - | - | |||||
Imputed Operating Lease Interest Expense | 222M | 135M | 178M | - | - | |||||
Imputed Operating Lease Depreciation | -61.56M | 53.76M | 72.02M | - | - | |||||
Maintenance & Repair Expenses, Total | 492M | 652M | 701M | - | - | |||||
Stock-Based Comp., COGS (Total) | 326M | 468M | 344M | 496M | 546M | |||||
Total Stock-Based Compensation | 326M | 468M | 344M | 496M | 546M |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















